Our staff add value to public sector effectiveness and the independent assurance of public sector administration and accountability, applying our professional and technical leadership to have a real impact on real issues.
The objective of the audit was to assess the adequacy of selected Australian Government entities’ practices and procedures to manage business continuity. To conclude against this objective, the ANAO adopted high-level criteria relating to the entities’ establishment, implementation and review of business continuity arrangements.
The audit examined the Aged Care Standards and Accreditation Agency Ltd's management of the residential aged care accreditation process. The audit focused on the Agency's implementation of a process to meet its legislative responsibilities, its business operations, people management, budgeting practices, use of information, and its quality assurance processes.
The audit examined whether the Department of Health and Ageing had the performance information necessary to administer the Australian Health Care Agreements. A strong focus of the audit was accountability for performance given the significant size of Commonwealth financial assistance, more than $29.6 billion over 5 years, provided to the States and Territories for the provision of health care services.
The audit reviewed the extent to which the Department of Health and Ageing (Health) had implemented the recommendations of Audit Report No. 13 of 1998-1999, Aboriginal and Torres Strait Islander Health Program, taking account of any changed circumstances or new administrative issues identified as impacting the implementation of these recommendations.
The audit reviewed the effectiveness of HIC's approach to customer service delivery to the Australian public as customers of Medicare. The primary issues examined were whether: . HIC manages its customer service delivery performance effectively;
HIC's approach to people management adequately supports customer service delivery;
HIC obtains adequate information from customers on their needs, expectations, and perceptions of HIC's service delivery; and
HIC provides adequate information to customers on its services and on the service standards that customers should expect.
The audit examined the administrative effectiveness of arrangements between Health and HIC, in relation to the management and administration of the Medicare Benefits Scheme and the Pharmaceutical Benefits Scheme. Health predominantly exercises a policy and leadership role within the health portfolio - HIC delivers a range of health services directly to the public and members of the health industry. Both agencies have stated that they recognise the importance of working together, as partners in their respective roles, to maximise their performance in the achievement of health portfolio outcomes and to discharge their respective responsibilities. This joint commitment is embodied in a written agreement - called the Strategic Partnership Agreement (SPA).
The overall objective of the audit was to determine whether Health's management and operation of selected IT systems:
met industry better practice;
met quality and service delivery parameters set by Health and, if applicable, by the Government; and
operate effectively, efficiently and economically.
The audit applied selected processes from CobiT (Control Objectives for Information and Related Technology) to assist with the assessment of key aspects of Health's management and operation of IT. The audit builds on ANAO's earlier IT audits using CobiT.
The Shadow Minister for Health and Ageing, Mr Stephen Smith, wrote to the Auditor-General on 11 March 2002 formally requesting an investigation into certain matters in relation to the 'Co-Location of National General Practice Organisations', a message detailed in the Health Portfolio Additional Estimates Statements 2001-02. The Federal President of the Australian Medical Association (AMA) Limited wrote to the Auditor-General on 11 March 2002, requesting a comprehensive audit of funding decisions by the Minister for Health and Ageing. The Australian National Audit Office has undertaken a preliminary examination of relevant papers relating to the 'GP House' matter. The preliminary examination focussed on whether or not due process was followed in making the decision to transfer funds between Outcomes. The preliminary examination also considered the procedures adopted by the Department of Health and Aged Care in developing the funding proposal, the advisory role played by the Department of Finance and Administration and specific advice provided by both departments to their Ministers. The examination further considered the disclosure of the related budget measure.
The 30 per cent Private Health Insurance Rebate is a financial incentive for individuals to purchase health insurance cover. The rebate provides for a reimbursement or discount of 30 per cent of the cost of private health insurance. It is available to all Australians who are eligible for Medicare and have private health insurance. The objective of the audit was to determine the effectiveness of Commonwealth Government agencies administration of the rebate.
This follow-up Audit reviewed the Department of Health and Ageing's implementation of the recommendations of Audit Report No. 36, 1999-2000, Home and Community Care. The objective of the follow-up audit was to assess the extent to which the Department had implemented the nine recommendations of Audit Report No. 36, 1999-2000. The audit examined areas relating to funding, guidance, fees, coordination with other aged and disability care programs, acquittals, accountability and data requirements, and records management.
The purpose of the audit was to examine the efficiency, effectiveness and accountability of the Therapeutic Goods Administration's performance in evaluating and approving prescription drugs for public use. In particular the audit focused on analysing elements of the regulatory process associated with the evaluation of prescription drugs. In this context the audit reviewed the administrative operations performed within the Department's Drug Safety and Evaluation Branch, the Australian Drug Evaluation Committee and the Business and Services Branch of the TGA, rather than any processes preceding or succeeding those activities.